Inventors:
Nancy Hathaway - Woodbridge NJ, US
Margery Mark - New Brunswick NJ, US
International Classification:
A61K 31/498, A61K 31/48, A61K 31/137, A61K 31/44, A61K 31/415, A61K 31/366
US Classification:
514250000, 514406000, 514284000, 514424000, 514471000, 514649000, 514663000
Abstract:
This invention is directed to the use of certain pharmaceutical compositions for treating and methods of treating Parkinson s disease. In particular, this invention is directed to pharmaceutical compositions for treating and methods of treating Parkinson s disease comprising the use of selective cyclooxygenase-2 inhibitors, such as rofecoxib, etoricoxib, celecoxib and valdecoxib, with and without concomitant use of one or more antiparkinson drugs.